These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26818864)
1. Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types. Pandya AA Curr Pharm Des; 2016; 22(14):2057-63. PubMed ID: 26818864 [TBL] [Abstract][Full Text] [Related]
2. Acute Administration of Desformylflustrabromine Relieves Chemically Induced Pain in CD-1 Mice. Weggel LA; Pandya AA Molecules; 2019 Mar; 24(5):. PubMed ID: 30866543 [TBL] [Abstract][Full Text] [Related]
3. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses. Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611 [TBL] [Abstract][Full Text] [Related]
4. Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain. Bagdas D; Ergun D; Jackson A; Toma W; Schulte MK; Damaj MI Eur J Pain; 2018 Jan; 22(1):84-93. PubMed ID: 28809075 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands. Weltzin MM; Schulte MK J Pharmacol Exp Ther; 2010 Sep; 334(3):917-26. PubMed ID: 20516140 [TBL] [Abstract][Full Text] [Related]
6. Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine. German N; Kim JS; Jain A; Dukat M; Pandya A; Ma Y; Weltzin M; Schulte MK; Glennon RA J Med Chem; 2011 Oct; 54(20):7259-67. PubMed ID: 21905680 [TBL] [Abstract][Full Text] [Related]
7. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats. Nikiforuk A; Litwa E; Krawczyk M; Popik P; Arias H Pharmacol Rep; 2020 Jun; 72(3):589-599. PubMed ID: 32207091 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator. Kim JS; Padnya A; Weltzin M; Edmonds BW; Schulte MK; Glennon RA Bioorg Med Chem Lett; 2007 Sep; 17(17):4855-60. PubMed ID: 17604168 [TBL] [Abstract][Full Text] [Related]
17. des-Formylflustrabromine (dFBr): A Structure-Activity Study on Its Ability To Potentiate the Action of Acetylcholine at α4β2 Nicotinic Acetylcholine Receptors. Dukat M; Jain A; German N; Ferrara-Pontoriero R; Huang Y; Ma Y; Schulte MK; Glennon RA ACS Chem Neurosci; 2018 Dec; 9(12):2984-2996. PubMed ID: 30028943 [TBL] [Abstract][Full Text] [Related]